Target intelligence / Profile preview

CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET)

Target
NEET
Molecular classification
Iron-sulfur cluster protein, CDGSH domain-containing protein, Redox-active protein, Mitochondrial outer membrane protein, Mitochondrial matrix protein
01

Overview

Mitochondrial NEET proteins, also known as CDGSH iron-sulfur domain-containing (CISD) proteins, are a unique class of [2Fe-2S] cluster-binding proteins located primarily in the mitochondria and endoplasmic reticulum. The family consists of three members in humans: CISD1 (mitoNEET), CISD2 (NAF-1), and CISD3 (Miner2), which play critical roles in regulating mitochondrial iron homeostasis, reactive oxygen species (ROS) levels, and bioenergetics (PMID: 17360355, 21825116). These proteins act as redox-sensitive switches that can transfer their iron-sulfur clusters to acceptor proteins, thereby modulating cellular pathways such as apoptosis, autophagy, and ferroptosis. Dysregulation of NEET proteins is implicated in a wide range of pathologies, including type 2 diabetes, neurodegenerative disorders like Parkinson's disease, and various cancers where they support tumor cell proliferation (PMID: 33184277, PMC8021574). NEET proteins were first identified as the mitochondrial targets of the thiazolidinedione class of anti-diabetic drugs, such as pioglitazone, which stabilize the [2Fe-2S] cluster and mitigate mitochondrial dysfunction (PMID: 17360355). Recent therapeutic strategies focus on developing small molecules that either stabilize or destabilize these clusters to treat metabolic diseases or induce ferroptosis in cancer cells. For instance, molecules like Mito-C and M1 have been designed to modulate mitochondrial morphology and iron levels, offering potential treatments for viral infections and metabolic syndrome (PMID: 33184277). Given their central role in maintaining organelle crosstalk and cellular health, NEET proteins represent a promising frontier for disease-modifying therapies in aging and chronic metabolic conditions.

Other names
Mitochondrial NEET proteinsCISD proteinsCDGSH iron-sulfur domain-containing protein 1 (CISD1)CDGSH iron-sulfur domain-containing protein 2 (CISD2)CDGSH iron-sulfur domain-containing protein 3 (CISD3)MitoNEETNutrient-deprivation autophagy factor 1 (NAF-1)Miner1Miner2ERISMiNT
02

Mechanism of action

Drugs targeting NEET proteins typically act by stabilizing or destabilizing the [2Fe-2S] cluster within the CDGSH domain, thereby modulating the rate of cluster transfer to acceptor proteins and regulating mitochondrial iron and ROS levels.

03

Biological functions

Iron-sulfur cluster transferMitochondrial iron homeostasisReactive oxygen species (ROS) regulationApoptosis regulationAutophagy regulationMitochondrial bioenergeticsCalcium homeostasisFerroptosis regulation
04

Disease associations

Type 2 diabetesObesityCancerWolfram Syndrome 2Neurodegenerative diseaseParkinson's diseaseAlzheimer's diseaseAgingCardiovascular diseaseInfection
05

Safety considerations

Off-target effects on other iron-sulfur proteinsPotential mitochondrial toxicity from excessive iron/ROS disruptionComplexity in achieving isoform-specific modulation (CISD1 vs. CISD2)
06

Interacting drugs

Pioglitazone

9 more in the full profile.

07

Biomarkers

Mitochondrial labile iron pool (mLI)Mitochondrial reactive oxygen species (mROS) levelsCISD2 expression levelsMitochondrial morphology (fragmentation/fusion ratio)

Beyond the preview

Go deeper on CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call